PlainRecalls

Mylan Laboratories Limited, (Nashik Fdf)

Compiled from official public sources by the publisher.

13 recalls on record · Latest: Dec 19, 2018

Subscribe to new Mylan Laboratories Limited, recalls (RSS)

Agency notice ledger

Federal filing book Mylan Laboratories Limited, LIGHT-BOOK · SINGLE-AGENCY

#1,190 of 14,151 · 13 notices · 0.012% archive

  • BOOK 13 notices
  • RANK #1,190 of 14,151
  • SHARE 0.012% archive
  • AGENCY FDA Drug (13)
  • CAT drugs
  • CATS 2 categories
  • LATEST Dec 19, 2018
  • PHOTO Access Scientific LLC

Nearest notice-volume peer: Access Scientific LLC (0 notice gap)

Mylan Laboratories Limited, (Nashik Fdf) accounts for about 0.012% of the 104,423-notice archive on 13 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Mylan Laboratories Limited,'s standing among 14,151 recalling firms

Mylan Laboratories Limited, (Nashik Fdf) ranks 1,190th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Mylan Laboratories Limited, vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

13 1190th of 14151 higher than 12,927 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Mylan Laboratories Limited, in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Mylan Laboratories Limited, (Nashik Fdf) holds about 0.012% of archive notices alongside 13 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Dec 19, 2018

Valsartan and Hydrochlorothiazide Tablets, USP 320/25 mg, (a) 90-count bottle (NDC 0378-6325-77), (b) 500-count bottles (NDC 0378-6325-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.
FDA Drug Moderate Dec 19, 2018

Valsartan and Hydrochlorothiazide Tablets, USP 160/25 mg, (a) 90-count bottle (NDC 0378-6323-77), (b) 500-count bottles (NDC 0378-6323-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.
FDA Drug Moderate Dec 19, 2018

Valsartan and Hydrochlorothiazide Tablets, USP 160/12.5 mg, (a) 90-count bottle (NDC 0378-6322-77), (b) 500-count bottles (NDC 0378-6322-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.
FDA Drug Moderate Dec 19, 2018

Valsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-5815-77.
FDA Drug Moderate Dec 19, 2018

Valsartan Tablets, USP 80 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5813-77.
FDA Drug Moderate Dec 19, 2018

Amlodipine and Valsartan Tablets, USP 10/160 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-1722-93.
FDA Drug Moderate Dec 19, 2018

Valsartan Tablets, USP 160 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5814-77.
FDA Drug Moderate Dec 19, 2018

Valsartan and Hydrochlorothiazide Tablets, USP 80/12.5 mg, (a) 90-count bottle (NDC 0378-6321-77), (b) 500-count bottles (NDC 0378-6321-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.
FDA Drug Moderate Dec 19, 2018

Amlodipine and Valsartan Tablets, USP 5/160 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-1721-93.
FDA Drug Moderate Dec 19, 2018

Amlodipine and Valsartan Tablets, USP 5/320 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-1723-93.
FDA Drug Moderate Dec 19, 2018

Valsartan and Hydrochlorothiazide Tablets, USP 320/12.5 mg, (a) 90-count bottle (NDC 0378-6324-77), (b) 500-count bottles (NDC 0378-6324-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.
FDA Drug Moderate Dec 19, 2018

Valsartan Tablets, USP 40 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-5807-93.
FDA Drug Moderate Dec 19, 2018

Amlodipine and Valsartan Tablets, USP 10/320 mg, 30-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., NDC 0378-1724-93.

Mylan Laboratories Limited, holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (13 here — thin-book).

Access Scientific LLC 13 Acclarent, Inc. 13 Advanced Bionics, LLC 13 Aequita Pharmacy 13 Alden Optical 13

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Amneal Pharmaceuticals, LLC 13 Ani Pharmaceuticals, Inc. 13 Bedford Pharmacy 13 Boehringer Ingelheim Pharmaceuticals, Inc. 13

Frequently Asked Questions

How many federal recall notices name Mylan Laboratories Limited,? ▼
PlainRecalls indexes 13 distinct federal recall events naming Mylan Laboratories Limited, (Nashik Fdf), aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Mylan Laboratories Limited, sit among other recalling firms? ▼
Mylan Laboratories Limited, (Nashik Fdf) ranks #1,190 of 14,151 by distinct recall-event count among 14,151 firms in this archive (91st percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Mylan Laboratories Limited,'s notices? ▼
FDA Drug accounts for 13 of this firm's 13 indexed notices.
What product category dominates Mylan Laboratories Limited,'s filing book? ▼
Filings for Mylan Laboratories Limited, (Nashik Fdf) span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Mylan Laboratories Limited, (Nashik Fdf): 13 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Mylan Laboratories Limited, (Nashik Fdf); individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026